Protein that interacts with C kinase 1 (PICK1) is a critical mediator of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) trafficking in neural synapses. However, its ubiquitous expression suggests that it may have other non-neural functions. Here we show that PICK1 antagonizes transforming growth factor beta (TGF-β) signaling by targeting TGF-β type I receptor (TβRI) for degradation. Biochemical analyses reveal that PICK1 directly interacts with the C-terminus of TβRI via its PDZ domain and acts as a scaffold protein to enhance the interaction between TβRI and caveolin-1, leading to enhanced lipid raft/caveolae localization. Therefore, PICK1 increases caveolin-mediated endocytosis, ubiquitination and degradation of TβRI. Moreover, a negative correlation between PICK1 expression and TβRI or phospho-Smad2 levels is observed in human breast tumors, indicating that PICK1 may participate in breast cancer development through inhibition of TGF-β signaling. Our findings reveal a non-neural function of PICK1 as an important negative regulator of TGF-β signaling.
Introduction
Transforming growth factor beta (TGF-β) regulates cell proliferation, differentiation, migration and death, and its abnormity has been closely related to pathology, including fibrosis, vascular disorders and cancer development [1] [2] [3] [4] [5] . Through a phosphorylation cascade, TGF-β type I receptor (TβRI), which is activated by the type II receptor (TβRII) in the ligand-bound receptor complex, transduces signaling to intracellular molecules, Smad proteins. Then, the activated Smad2/3-Smad4 complex translocates from the cytoplasm into the nucleus, and regulates the expression of target genes [6] . As TGF-β plays vital roles in many physiological processes, its duration and intensity are under tight controls [7] .
TGF-β receptors link extracellular stimulation to intracellular responses, so their distributions and stabilities are critical for TGF-β signal transduction [8, 9] . Like many other receptors on cell surface, TGF-β receptors undergo constant internalization, which is mediated by two major endocytic pathways: clathrin-mediated endocytosis and caveolin-mediated endocytosis [10] . The clathrin-mediated endocytosis of TGF-β receptors facilitates phosphorylation of downstream R-Smad and results in enhanced signaling. In contrast, caveolin-mediated endocytosis, which mainly occurs in lipid raft region, inhibits signaling through promoting receptors' ubiquitination followed by degradation [10, 11] . The dynamic balance between these two pathways maintains appropriate response of a cell to TGF-β stimulation.
Protein that interacts with C kinase 1 (PICK1) is a PDZ (PSD-95/Dlg/ZO-1) domain and BAR (Bin/amphiphysin/Rvs) domain containing protein first cloned as a PKC-binding partner through yeast two hybrid system [12] . As a peripheral protein, PICK1 has been reported to interact with a series of membrane proteins including α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) [13] [14] [15] [16] , acid-sensing ion channel (ASICs) [17] and ErbB2/Her-2 [18] . In most of the cases, PICK1 acts as a critical regulator of membrane receptors' subcellular trafficking to modulate neural processes such as learning and memory [19, 20] . PICK1 is widely expressed in brain, testis, heart, lung, liver, kidney and muscle [12] . Its abnormal expression in brain has been linked to schizophrenia and other mental disorders [21] [22] [23] . However, the significance of PICK1 in other organs has not been well characterized. Its potential effects on signal transduction and related diseases remain unclear. Recent evidences suggest that PICK1 may affect human cancer development [18, [24] [25] [26] , in which TGF-β signaling has been reported to play significant roles [5] .
A PDZ domain-containing protein GIPC (GAIPinteracting protein, C terminus) has been shown to interact with the TGF-β type III receptor and regulate TGF-β signaling [27] , but no PDZ proteins have been reported to interact with TβRI. In this study, we demonstrated that PICK1 antagonized TGF-β signaling and released its inhibition of cell growth. We found that PICK1 bound to TβRI directly and facilitated its internalization through caveolin-mediated endocytic pathway, which led to degradation of TβRI and turnoff of the signal. Moreover, the restriction of PICK1 on TGF-β signaling was observed in human breast cancer, which indicated that PICK1 might affect breast cancer development in a TGF-β-dependent
Results

PICK1 attenuates TGF-β/Smad signaling
Sequence analysis predicted that the C-terminus of TβRI (QQEGIKM) might function as a potential PICK1 PDZ-binding motif (-X-Φ-X-Φ, where X stands for any residues and Φ stands for hydrophobic residues), thus suggesting that PICK1 may regulate trafficking and function of TβRI. To assess this possibility, we investigated the effect of PICK1 on TGF-β signaling by comparing TGF-β responses between Pick1 +/+ and Pick1 -/-mouse embryonic fibroblast (MEF) cells. Reporter assay using CAGA-luciferase revealed that TGF-β treatment increased the Smad activation in Pick1 +/+ MEFs, and TGF-β response was markedly enhanced in Pick1 -/-MEFs ( Figure 1A ). Consistently, Pick1
-/-MEFs were more sensitive to TGF-β in the induction of the morphologic change to an elongate shape than Pick1 +/+ MEFs ( Figure 1B) . Besides, loss of PICK1 promoted the mobility of MEFs upon TGF-β stimulation ( Figure 1C ). These data indicate that deletion of PICK1 enhances TGF-β response. To verify this, we employed RNA interference to knock down PICK1 expression (Supplementary information, Figure S1 ) and found that knockdown of PICK1 by shRNAs led to enhanced TGF-β response ( Figure  1D ). These data further support that disruption of PICK1 expression sensitizes cells to TGF-β responses.
To confirm the negative effect of PICK1 on TGF-β signaling, we overexpressed PICK1 and examined its effect on TGF-β-induced expression of the reporters CAGA-luciferase and 3TP-luciferase. Overexpression of PICK1 inhibited the transcriptional activity of TGF-β in HEK293, NMuMG and HaCaT cells in a dose-dependent manner ( Figure 1E and Supplementary information, Figure S2 ). TGF-β upregulates the expression of p21 and p15 via Smad proteins [28, 29] . The TGF-β-induced expression of p21 and p15 was also attenuated by PICK1 in NMuMG cells, as shown by qRT-PCR ( Figure 1F ). In agreement with this, the antiproliferative effect of TGF-β was abolished by PICK1 overexpression in NMuMG cells (Supplementary information, Figure S3 ).
As Smad2/3 proteins are the main mediators of TGF-β signaling and activated by TGF-β receptors via C-terminal serine phosphorylation, we then assessed the effect of PICK1 on Smad phosphorylation. Although the Smad2 level was lower in Pick1 +/+ MEFs, stronger phosphorylation was observed in Pick1 -/-MEFs upon TGF-β treatment ( Figure 1G ), while overexpression of PICK1 decreased TGF-β-induced Smad2 phosphorylation in NMuMG cells ( Figure 1H ). FSC231 is a small-molecule inhibitor of PICK1, which abolishes the interaction of PICK1 PDZ domain with other proteins [30] . As shown in Figure 1I , FSC231 enhanced TGF-β-induced Smad2 phosphorylation. Taken together, these data suggest that PICK1 negatively modulates TGF-β/Smad signaling.
PICK1 promotes TβRI degradation
As PICK1 attenuates TGF-β/Smad signaling, we then assessed whether PICK1 regulates TGF-β receptor stability. Immunblotting analysis revealed that the TβRI protein level was higher in Pick1 -/-MEFs than in Pick1
MEFs ( Figure 2A) . However, the TβRI mRNA level was similar in these cells (data not shown). These data suggest that PICK1 may modulate TβRI stability. To verify this, we followed TβRI turnover after proteins synthesis was blocked by cycloheximide (CHX) and found that loss of PICK1 resulted in a prolonged half-life of TβRI in MEFs ( Figure 2B ). Consistently, overexpression of PICK1 destabilized TβRI in HEK293T cells, which could be rescued by the lysosome inhibitors NH 4 Cl and chloroquine or the proteasome inhibitor MG132 ( Figure 2C ), indicating that both the lysosome and proteasome degradation pathways are involved in PICK1-mediated degradation of TβRI. As Smurf-mediated ubiquitination of TβRI is required for its degradation [31, 32] , we examined whether PICK1 affected TβRI ubiquitination. Indeed, PICK1 enhanced TβRI ubiquitination ( Figure 2D ).
Protein kinase C is important in regulating cellular functions of PICK1 [33] , however, PICK1-mediated degradation of TβRI was not markedly influenced by it (Supplementary information, Figure S4 ).
PICK1 interacts with TβRI via its PDZ domain
To address how PICK1 controls TβRI turnover, we examined whether PICK1 interacts with TGF-β receptors. In HEK293 cells, co-immunoprecipitation revealed that TβRI associated with PICK1 at the endogenous protein level upon TGF-β stimulation ( Figure 3A ). When they were overexpressed, the interaction between PICK1 and TβRI could be detected without TGF-β treatment ( Figure 3B ). It has been shown that the PDZ domain of PICK1 mediates its interaction with other proteins [19] . To test whether the PICK1-TβRI interaction was direct, we generated recombinant PICK1 PDZ domain and GST-fused intracellular domain of TβRI(ICD). GST pull-down demonstrated that the PDZ domain could directly bind to TβRI(ICD) ( Figure 3C ). FSC231 interfered with the interaction between TβRI and PICK1(PDZ) ( Figure 3D ), further supporting that PICK1 directly interacts with TβRI via its PDZ domain. It has been reported that mutation of Lys27 and Asp28 to Ala can completely disrupt the binding of the PICK1 PDZ domain to other proteins [13, 34] . Consistently, only wild-type PICK1(PDZ), but not the mutant K27A,D28A, was co-immunoprecipitated 
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npg by TβRI ( Figure 3E ). We further identified the C-terminal tail of TβRI as a PDZ-binding motif as mutation of the residues Ile501 and Met503 to Asp at the TβRI tail abolished its interaction with the PICK1 PDZ domain ( Figure 3F ). The data in Figure 3B showed that PICK1 also weakly interacted with TβRII. To explore whether this interaction requires the presence of TβRI, we tested whether PICK1 interacts with TβRII in L17 cells that do not express TβRI [35] . As shown in Figure 3G , PICK1 interacted with TβRII only when TβRI was co-expressed. As overexpressed receptors can form a complex in the absence of TGF-β [36, 37] , these results implicate that PICK1 associates with TβRII through TβRI. 
Caveolin-1 is essential for PICK1-mediated degradation of TβRI
PICK1 acts as a scaffold protein regulating membrane trafficking of AMPK receptors [19, 20] . It has been suggested that caveolin-1-mediated endocytosis is critical for TβRI degradation [10, 38] . Therefore, we tested whether caveolin-1 is involved in PICK1-mediated TβRI degradation. First, we examined the effect of caveolin-1 on PICK1 inhibition of TGF-β transcriptional responses. As shown in Figure 4A , caveolin-1 knockdown with siR-NA abolished the inhibitory effect of PICK1 on TGF-β-induced expression of CAGA-luciferase. Consistent with npg this, PICK1-mediated degradation of TβRI was prevented when caveolin-1 was depleted ( Figure 4B ). These data suggest that caveolin-1 is required for PICK1-mediated inhibition of TGF-β signaling and TβRI degradation. To elucidate the relationship of PICK1 and caveolin-1 in regulation of TGF-β signaling, we investigated whether PICK1 interacts with caveolin-1. Co-immunoprecipitation showed that PICK1 interacted with caveolin-1 at the endogenous protein levels in NMuMG cells ( Figure  4C ) and at the ectopically expressed protein levels in HEK293T cells ( Figure 4D ). Domain mapping revealed that the 1-152 residues of PICK1 containing the PDZ domain was essential for its interaction with caveolin-1 ( Figure 4E and 4F) . However, the binding ability of the 1-152 fragment to caveolin-1 was weaker than that of full-length PICK1, suggesting that other domains may also contribute to this interaction.
As PICK1 interacts with both TβRI and caveolin-1, it might serve as a scaffold protein promoting the TβRI-caveolin-1 association. Indeed, we observed that the interaction between TβRI and caveolin-1 was greatly attenuated in Pick1 -/-MEFs ( Figure 4G ). Consistently, the TβRI-caveolin-1 association was markedly enhanced by wild-type PICK1 although the total TβRI level was lower as the result of PICK1-mediated degradation (Figure 4H) . However, none of the PDZ domain, the BAR domain or K27A,D28A mutant had effect on the TβRI-caveolin-1 interaction and TβRI degradation. PICK1 K266E,K268E (2K2E) and K251E,K252E,K257E (3K3E) mutants, which lose the lipid-binding ability [39] , could not disrupt the PICK1 activity to interact with TβRI and promote its degradation. The BAR domain of PICK1 is critical for PICK1 dimerization [40] . Overexpression of the BAR domain could bind to wild-type PICK1 and then disrupt the wildtype PICK1 dimerization efficiently (Supplementary information, Figure S5 ). To test whether dimerization is important for PICK1 to promote the interaction between TβRI and caveolin-1, we co-expressed the BAR domain and found that it decreased the PICK1-enhanced TβRI-caveolin-1 interaction ( Figure 4I ), implicating that PICK1 dimerization is critical for its enhancement on the TβRI-caveolin-1 interaction.
PICK1 facilitates lipid raft localization and caveolinmediated endocytosis of TβRI
As PICK1-enhanced TβRI degradation is dependent on caveolin-1, we assessed whether localization of TβRI in lipid raft is affected by PICK1 in NMuMG cells. In GFP-expressing control cells, TβRI was distributed in both lipid raft (33%) and non-lipid raft fractions, while in the cells expressing PICK1, more TβRI was found in lipid raft fractions (60%) (Figure 5A and 5B).
TβRI can be internalized via both clathrin-mediated and caveolin-mediated endocytosis [10] , and caveolinmediated endocytosis turns off TGF-β signaling by promoting TβRI degradation. These two endocytosis pathways are maintained at a dynamic balance, and blockage of one pathway would lead to amplification of the other [38] . Endocytosis of biotin-labeled TβRI was employed to study the effect of PICK1 on this dynamic balance of the receptor [41] . Clathrin heavy chain siRNA and caveolin-1 siRNA were used to block clathrin-mediated endocytosis and caveolin-mediated endocytosis, respectively ( Figure 5C and Supplementary information, Figure  S6 ). We found that most TβRI internalization into the cell within 5 min was mainly through a rapid clathrinmediated endocytosis ( Figure 5C ), which was blocked by PICK1 ( Figure 5D ), suggesting that PICK1 can prevent TβRI from the fast internalization through the clathrindependent pathway. In agreement with this, the majority of internalized TβRI was co-stained with the caveolin-1-positive vesicles in Pick1 +/+ MEFs, while the proportion of TβRI-caveolin-1 co-localization was dramatically de-
-/-MEFs ( Figure 5E ). Consistently, the co-localization between internalized TβRI and EEA1 was increased in Pick1 -/-cells ( Figure 5E ). These data suggest that PICK1 can shift the internalization of TβRI from the clathrin-dependent pathway to the caveolin-dependent pathway.
To address whether dimerization is important for PICK1 to mediate caveolin-dependent endocytosis of TβRI, we expressed the BAR domain in HeLa cells and found that disruption of PICK1 dimerization markedly decreased the co-localization between endocytic TβRI and caveolin-1 (Supplementary information, Figure S7) .
These results together suggest that PICK1 facilitates lipid raft localization and caveolin-mediated endocytosis of TβRI and thus accelerates TβRI degradation.
PICK1 expression is negatively correlated with TGF-β signaling in human breast cancer
Deregulation of TGF-β signaling contributes to tumorigenesis. It has been reported that PICK1 is highly expressed in breast cancer cells [26] . To investigate whether the negative regulation of PICK1 on TGF-β signaling contributes to breast cancer development, we first examined the effect of PICK1 on the antiproliferative activity of TGF-β in breast epithelial MCF10A cells. As shown in Figure 6A and 6B, overexpression of PICK1 not only attenuated G1 phase arrest induced by TGF-β, but also remarkably decreased mRNA levels of PAI1, p21 and p15, the latter two genes playing pivotal roles in cell proliferation. Immunohistochemistry analysis revealed that PICK1 expression and phosphor-Smad2 level, a TGF-β signaling indicator, showed a significant negative correlation (P = 4.3e-12; correlation coefficient = 0.54) in 141 breast cancer samples ( Figure 6C ). Furthermore, this negative correlation was also observed in 11 fresh breast tumors ( Figure 6D ). These results suggest that PICK1 may promote tumorigenesis by inhibiting TGF-β signaling.
Discussion
TGF-β signaling is tightly regulated to ensure its appropriate activity in embryo development and tissue homeostasis. PICK1 is a scaffold protein to control trafficking of several membrane receptors, including AMPA receptor and ASIC, and has been implicated to function in nervous system and male fertility [17, 19, 20, 42] . Here, we identify PICK1 as a novel negative regulator of TGF-β signaling by modulating subcellular localization and trafficking of TβRI. By promoting the interaction between TβRI and caveolin-1, PICK1 facilitates caveolinmediated endocytosis of cell surface TβRI, resulting in TβRI degradation and signaling termination ( Figure 5F ). npg TGF-β receptors are dynamically distributed on the plasma membrane [10] . Interleukin-6 [43] , ADAM12 [44] and cholesterol depletion [45] can partition TβRI from the lipid raft microdomains into non-lipid raft regions, while hyaluronan [46] and the polysaccharide heparin sulfate [47] promote lipid raft localization of TβRI. Several lines of evidence showed that caveolin, which is enriched in lipid rafts, is required for TβRI turnover [38, 46, 48, 49] . In the current study, we found that PICK1 could promote caveolae localization of TβRI. This is achieved for PICK1 to function as a scaffold protein to bridge TβRI and caveolin-1. Consistently, less TβRI was found in Pick1 -/-cells. Interestingly, unlike AMPA receptor, PICK1-mediated regulation of membrane distribution of TβRI is independent of protein kinase C activity. Of note, our previous work demonstrated that lipid raft location of TβRI is also required for TGF-β-induced activation of MAPKs [49] . We observed that loss of PICK1 or knockdown of caveolin-1 led to enhanced phosphorylation level of p38 (data not shown), supporting the notion that TβRI localization in caveolae mainly modulates receptor turnover while its distribution in non-caveolae lipid rafts is important for MAPK activation.
TβRI enters the cell via both clathrin-or lipid raftmediated endocytosis [10, 50] . These two distinct endocytic pathways predetermine whether TβRI promotes a signaling response or is degraded [9] . Clathrin-mediated endocytosis of TβRI into early endosomes enhances TGF-β signaling while lipid raft/caveolin-mediated endocytosis enhances ubiquitination and degradation of TβRI. Consistent with this, our biotin-labeled TβRI endocytosis assay revealed that rapid internalization of TβRI is mainly through clathrin-mediated endocytosis, indicating that clathrin-mediated endocytosis may be important for immediate cell response to TGF-β stimulation. Furthermore, PICK1 inhibits rapid clathrin-mediated internalization of TβRI, suggesting that PICK1-enhanced caveolae localization of TβRI leads to signal turnoff not only by promoting TβRI degradation, but also by shielding the receptor from entering early endosomes.
PICK1 is ubiquitously expressed in many tissues outside the nervous system [12] , however, its non-neural functions remains largely unclear. Increased expression of PICK1 was reported in breast cancer [26] . We observed a negative correlation between PICK1 and p-Smad2 levels in breast cancer samples, indicating that PICK1 may promote breast cancer formation by restricting TGF-β signaling. In agreement with this, our results revealed that overexpression of PICK1 in breast epithelial cells abolished TGF-β-induced growth inhibition.
In summary, this study provides the evidence that PICK1 facilitates TGF-β receptor degradation in a caveolin-dependent manner. Our findings extend the understanding of the dynamic regulation of TGF-β receptors and offer new insight into the cellular and pathological functions of PICK1.
Materials and Methods
Plasmids and RNA interference
Human PICK1 was cloned into pCMV-Myc, Flag-pCDNA3.1 and PEBG1 for eukaryotic expression. MBP-PICK1 was generated by subcloning into the EcoRI and SalI sites of pMal-s (a gift from Jingming Yuan) for prokaryotic expression. pCMV-Myc-PICK1 K27A, D28A, 2K2E and 3K3E were constructed by the mutagenesis of pCMV-Myc-PICK1 using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) and confirmed by sequencing. For RNA interference, two PICK1 shRNA constructs were generated using pll3.7. The targeted sequences are as follows: 5′-GAAG-TACCTGGACGTGAAG-3′ and 5′-GAGGAGCTGGAGCG-GACCG-3′. siRNAs targeting caveolin-1 and clathrin heavy chain were purchased from GenePharma. The sequences of siRNAs were as follows: negative control, sense 5′-UUCUCCGAACGU-GUCACGUTT-3′, anti-sense 5′-ACGUGACACGUUCGGA-GAATT-3′; caveolin-1, sense 5′-GGGACAUCUCUACAC-CGUUCC-3′, anti-sense 5′-GGAACGGUGUAGAGAUGU-CCC-3′; clathrin heavy chain, sense 5′-GUAAUCCAAUUCGAA-GACCTT-3′, anti-sense 5′-GGUCUUCGAAUUGGAUUACTT-3′.
Reagents and antibodies
FSC231 was a generous gift from Dr Ulrik Gether. Propidium iodide, NH 4 Cl, chloroquine and cycloheximide (CHX) were obtained from Sigma, MG132 from Calbiochem, TGF-β1 from R&D Systems, HRV3C from Novagen, Transferrin conjugates (Fluor 488) from Invitrogen. Antibodies were purchased from ABR (α-Adaptin2 and α-PICK1), BD Biosciences (α-caveolin-1), Cell Signaling (α-Myc tag), Millipore (α-Myc tag and α-p-Smad2), Proteintech Group (α-PICK1), Santa Cruz (α-GST tag, α-HA tag, α-PICK1, α-Smad2, α-TβRI, α-TβRII and α-tubulin), Sigma (α-Flag tag M2), eBioscience (Rabbit TrueBlot HRP-conjugated anti-rabbit lgG), GE Healthcare (ECL HRP-linked anti-mouse lgG and ECL HRP-linked anti-rabbit lgG) and Jackson ImmunoResearch (fluorescein isothiocyanate (FITC)-conjugated anti-mouse and tetramethylrhodamine β-isothiocyanate (TRITC)-conjugated anti-rabbit).
Cell lines and transfection
HEK293, HEK293T, HeLa, HaCaT, NMuMG cells and MEFs were maintained in DMEM medium supplemented with 10% FBS (Hyclone) in a 37 °C humidified incubator containing 5% CO 2 . L17 cells were maintained in MEM medium with 10% FBS and MCF10A was maintained in MCF10A specific culture medium. Transfection was performed with VigoFect (Vigorous) and Lipofectamine 2000 (Invitrogen) following the manufacturer's recommendations.
Pick1
-/-mice and MEF isolation Pick1 -/-mice have been reported [42] . MEFs were isolated and cultured as previously described [51] . 
Adenoviral expression
Ad-EGFP and Ad-PICK1 were generated with AdEasy™ Adenoviral Vector System (Stratagene). PICK1 was cloned into the XhoI and HindIII sites of pShuttle-CMV, and then transfered to pAdEasy-1 vector using homologous recombination in vivo in BJ5183 cells. Linearized pAdEasy-1-PICK1 produced viral stocks after transfection into 293A cells.
Reporter assay, immunoblotting, immunofluorescence, immunoprecipitation and flow cytometry
These assays were performed as previously described [52, 53] .
Quantitative RT-PCR (qRT-PCR)
Total RNA was extracted with Trizol reagent (Invitrogen) and cDNA was synthesized with Revertra Ace (Toyobo). A Mx3000p Quantitative PCR system (Stratagene) was employed to perform qRT-PCR using EvaGreen dye (Biotium). The primers were: mouse p21 (5′-GTGATTGCGATGCGCTCATG-3′ and 5′-TCTCTTGCAGAAGACCAATC-3′), mouse p15 (5′-CCCT-GCCACCCTTACCAGA-3′ and 5′-CAGATACCTCGCAATGT-CACG-3′), mouse GAPDH (5′-AAGAAGGTGGTGAAGCAG-3′ and 5′-TCATACCAGGAAATGAGC-3′), human p21 (5′-TG-GAGACTCTCAGGGTCGAAAA-3′ and 5′-GCGTTTGGAGT-GGTAGAAATCTG-3′), human p15 (5′-CACCGTTGGC-CGTAAACTTAAC-3′ and 5′-TAATGAAGCTGAGCCCAG-GTCT-3′), human PAI1 (5′-GAGACAGGCAGCTCGGATTC-3′ and 5′-GGCCTCCCAAAGTGCATTAC-3′) and human GAPDH (5′-GAAGGTGAAGGTCGGAGTC-3′ and 5′-GAAGATGGT-GATGGGATTTC-3′).
In vitro pull-down assay
MBP-PICK1 and GST-TβRI (intracellular domain, ICD) fusion proteins were expressed in E. coli and purified with glutathionesepharose (Amersham Pharmacia Biotech) or amylose resin (New England Biolabs). PDZ domain of PICK1 was obtained after onbeads-cleavage of MBP-PDZ with HRV3C. The beads binding MBP-PICK1 or GST-TβRI(ICD) were washed extensively with binding buffer (50 mM Tris-HCl pH 8.0, 250 mM NaCl) and were incubated with purified TβRI(ICD) or PICK1(PDZ) for 1 h, respectively. Bound proteins were extracted with loading buffer and analyzed by immunoblotting.
Receptor endocytosis assay and quantitative analysis of endogenous TβRI endocytosis by biotinylation
HEK293 cells were placed on ice, washed twice with ice-cold PBS and then labeled with 0.2 mM Sulfo-NHS-SS-biotin (Thermo) in PBS for 30 min. After washing twice with ice-cold PBS and replacing with pre-warmed DMEM, dishes were placed in 37 °C incubator for 5 min, allowing for TβRI endocytosis. All dishes were then returned to ice and washed once with ice-cold PBS to stop membrane trafficking. To strip biotin remaining on cell surface, cells were treated twice with stripping buffer (50 mM cold L-Glutathione reduced, 75 mM NaCl, 75 mM NaOH, and 10% FBS) at 4 °C for 20 min. The cells are lysed in lysis buffer (10 mM EDTA, 1% Triton X-100, 0.1% SDS and protease inhibitors in PBS) and incubated with streptavidin beads (Thermo) for 1 h at 4 °C. Strptavidin-precipitated TβRI protein was detected with immunoblotting. The biotinylated TβRI remaining within the cells should be compared to the total TβRI level on cell surface before stripping.
Antibody-labeled TβRI endocytosis
Pick1
+/+ and Pick1 -/-MEFs were placed on glass coverslips and transfected with TβRI tagged with Myc right after signal peptide. Two days later, cells were washed twice with ice-cold PBS, followed by incubation with α-Myc tag antibody (1:100 in PBS containing 10% FBS) for 6 h at 4 °C. Then cells were washed with cold PBS twice and returned to 37 °C for 40 min, allowing endocytosis to occur. The cells were fixed and prepared for immunofluorescence analysis.
Lipid raft fractionation
Lipid raft fractionation was performed as previously described [49] .
Immunohistochemistry and tissue array
Immunohistochemistry was performed with human breast tumor tissue array (grades I-III with normal controls) by Cybrdi Inc (Xi'an, China). A spearman's correlation test was used to analyze the relationship between PICK1 and p-Smad2.
Tumor samples
Fresh breast cancer tumor samples were obtained from the First Affiliated Hospital of Nanchang University by following the Ethics Committee guideline and stored at −80 °C. The frozen tissue was weighed, cut into small pieces and homogenized in lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 0.5% NP40, 1 mM EDTA, 1% SDS) with Complete Protease Inhibitor cocktail (Roche) and PhosSTOP phosphatase inhibitor (Roche).
Statistic analysis
The band intensity was quantitated with BandScan 5.0. Student's t-test was performed in statistic analysis.
